Cardiovascular changes in sickle cell anaemia

R A Adebayo1, M O Balogun, N O Akinola

  • 1Department of Medicine, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.

Insights

Sickle cell anaemia (SCA) significantly impacts cardiac health in Nigeria, yet cardiovascular involvement data is scarce. Greater awareness of SCA

Area of Science:

  • Cardiology
  • Hematology
  • Public Health

Background:

  • Sickle cell anaemia (SCA) is Nigeria's most prevalent inherited hemoglobinopathy, causing significant morbidity and mortality, especially in children.
  • Cardiac manifestations are a key feature of SCA, but data on cardiovascular involvement in Nigeria and Africa is limited.
  • The growing prevalence of SCA necessitates increased awareness of its associated cardiac complications.

Purpose of the Study:

  • To review the clinical features, cardiac structure and function changes (at rest and during exercise), pathology, and associated heart diseases in SCA.
  • To highlight recent global advancements in understanding cardiovascular changes in SCA.
  • To emphasize data from Nigerian studies on cardiovascular involvement in SCA.

Main Methods:

  • Literature review focusing on clinical features, cardiac structure and function, pathology, and associated heart diseases in SCA.
  • Emphasis on data derived from Nigerian studies.
  • Inclusion of recent global progress in understanding cardiovascular changes in SCA.

Main Results:

  • SCA presents with significant cardiac manifestations, including changes in cardiac structure and function.
  • There is a paucity of specific data on cardiovascular involvement in SCA within Nigeria and the broader African context.
  • Global research is advancing the understanding of cardiovascular changes in SCA.

Conclusions:

  • Cardiac involvement is a critical aspect of sickle cell anaemia, demanding greater clinical attention in Nigeria.
  • Further research, particularly utilizing Nigerian data, is crucial to fully understand and manage cardiovascular complications of SCA.
  • Increased awareness among healthcare providers and the public regarding cardiac issues in SCA is essential.

Related Concept Videos

Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...